OSFAR - Pharmaceutical Observatory | SDA Bocconi School of Management

OSFAR

Pharmaceutical Observatory


Activities

Since 1997, OSFAR, the Pharmaceutical Observatory of CERGAS SDA Bocconi collects, systematizes and analyzes:

  • qualitative data on public policies and the management systems of the pharmaceutical assistance, in particular those of licensed pharmacies
  • quantitative data on the trend of public and private pharmaceutical expenditure at international, national and regional levels
  • the effects of pharmaceutical assistance policies and management systems on the expenditure trend.

The data collected are then used by OSFAR to prepare the Report: an analysis of public and private pharmaceutical expenditure at an international, national and regional level.

Research team
Companies registered in 2017-18
GSK, Novartis, MSD Italia, Janssen – Cilag SpA, Bayer, Roche, Boehringer Ingelheim, Takeda, Sanofi, Pfizer, Astrazeneca, Abbvie

Publications

The main activity of OSFAR, the Pharmaceutical Observatory of SDA Bocconi is the annual publication of the report, which contains:

  • a quantitative analysis of macro-variables relating to the economic and healthcare sector systems (national and international)
  • an analysis of public and private pharmaceutical expenditure and consumption at national and regional level
  • forecasts of public and private pharmaceutical expenditure and consumption for the current and following year;
  • an analysis of the regulation policies for the pharmaceutical sector and their effects on the expenditure trend.